deltatrials
Recruiting PHASE2/PHASE3 INTERVENTIONAL 1-arm NCT02395497

Human Penile Allotransplantation

Sponsor: Johns Hopkins University

Conditions Amputation Amputation, Traumatic Amputation, Traumatic/Surgery Congenital Anomaly, Male Genitalia Penis/Injuries Penis/Surgery Penis/Transplantation Urologic Surgical Procedures, Male Wounds and Injuries
Interventions Monoclonal Antibody (Humanized Anti-CD52) Penile Allotransplantation Tacrolimus
Updated 16 times since 2017 Last updated: Jul 3, 2025 Started: Jun 30, 2014 Primary completion: Jun 30, 2034 Completion: Jun 30, 2039
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2/PHASE3 trial investigates Amputation and Amputation, Traumatic and is currently actively recruiting participants. Johns Hopkins University leads this study, which shows 16 recorded versions since 2014 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Oct 2017 · 9 months · monthly snapshot~Oct 2017 – ~Nov 2017 · 31 days · monthly snapshot~Nov 2017 – ~Jun 2018 · 7 months · monthly snapshot~Jun 2018 – ~Nov 2018 · 5 months · monthly snapshot~Nov 2018 – ~Apr 2019 · 5 months · monthly snapshot~Apr 2019 – ~May 2019 · 30 days · monthly snapshot~May 2019 – ~May 2020 · 12 months · monthly snapshot~May 2020 – ~Jan 2021 · 8 months · monthly snapshot~Jan 2021 – ~Jun 2021 · 5 months · monthly snapshot~Jun 2021 – ~Sep 2021 · 3 months · monthly snapshot~Sep 2021 – ~Sep 2022 · 12 months · monthly snapshot~Sep 2022 – ~Sep 2023 · 12 months · monthly snapshot~Sep 2023 – ~Jul 2024 · 10 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Aug 2025 · 11 months · monthly snapshot~Aug 2025 – present · 11 months · monthly snapshot

Change History

16 versions recorded

  1. Aug 2025 — Present [monthly]

    Recruiting PHASE2/PHASE3

  2. Sep 2024 — Aug 2025 [monthly]

    Recruiting PHASE2/PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE2/PHASE3

    Phase: PHASE2_PHASE3 → PHASE2/PHASE3

  4. Sep 2023 — Jul 2024 [monthly]

    Recruiting PHASE2_PHASE3

  5. Sep 2022 — Sep 2023 [monthly]

    Recruiting PHASE2_PHASE3

▶ Show 11 earlier versions

  1. Sep 2021 — Sep 2022 [monthly]

    Recruiting PHASE2_PHASE3

  2. Jun 2021 — Sep 2021 [monthly]

    Recruiting PHASE2_PHASE3

  3. Jan 2021 — Jun 2021 [monthly]

    Recruiting PHASE2_PHASE3

  4. May 2020 — Jan 2021 [monthly]

    Recruiting PHASE2_PHASE3

  5. May 2019 — May 2020 [monthly]

    Recruiting PHASE2_PHASE3

  6. Apr 2019 — May 2019 [monthly]

    Recruiting PHASE2_PHASE3

  7. Nov 2018 — Apr 2019 [monthly]

    Recruiting PHASE2_PHASE3

  8. Jun 2018 — Nov 2018 [monthly]

    Recruiting PHASE2_PHASE3

  9. Nov 2017 — Jun 2018 [monthly]

    Recruiting PHASE2_PHASE3

  10. Oct 2017 — Nov 2017 [monthly]

    Recruiting PHASE2_PHASE3

  11. Jan 2017 — Oct 2017 [monthly]

    Recruiting PHASE2_PHASE3

    First recorded

Jun 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Johns Hopkins University
Data source: Johns Hopkins University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations